Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/5014
Title: Olanzapine treatment in choreoathetosis due to bilateral striopallidodentate calcinosis
Authors: Balaban, N.
Sahiner, T.
Degirmenci, Eylem
Keywords: Choreo-athetosis
Olanzapine
Striopallidodentate calcinosis
calcium
olanzapine
parathyroid hormone
phosphorus
aged
anamnesis
article
calcinosis
calcium blood level
case report
choreoathetosis
female
human
hypoparathyroidism
involuntary movement
parathyroid hormone blood level
phosphate blood level
scoring system
side effect
striopallidodentate calcinosis
treatment outcome
white matter
Abstract: Bilateral Idiopathic Striopallidodentate Calcinosis (BISPDCs) refers to idiopathic calcification of the basal ganglia and secondary striato-dentate calcinosis. Its definition comprises numerous metabolic abnormalities including disturbances of calcium and phosphorous metabolism. In this article, a case with BISPDCs secondary to hypoparathyroidism who presented with generalized choreoathetosis has been reported. A daily dose of 2.5 mg of olanzapine has been initiated and increased gradually up to doses 10 mg/daily. In six weeks time, the patient was almost free from choreoathetosis. Thus, olanzapine may be a good choice at the symptomatic treatment of choreoathetosis due to BISPDCs.
URI: https://hdl.handle.net/11499/5014
ISSN: 1017-7833
Appears in Collections:Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection
Tıp Fakültesi Koleksiyonu

Show full item record



CORE Recommender

SCOPUSTM   
Citations

1
checked on Nov 16, 2024

Page view(s)

30
checked on Aug 24, 2024

Google ScholarTM

Check





Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.